Arcadia Biosciences, Inc.
RKDA
$3.15
$0.155.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -520.17% | 207.26% | -42.45% | 37.20% | 28.92% |
| Total Depreciation and Amortization | -86.60% | -48.68% | -22.97% | -41.20% | -14.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 185.17% | -764.03% | 804.25% | 71.57% | 11.65% |
| Change in Net Operating Assets | -377.54% | -17.22% | 61.01% | 37.27% | 92.35% |
| Cash from Operations | 17.22% | 50.53% | 46.71% | 39.27% | 48.81% |
| Capital Expenditure | -- | -- | -- | -- | 40.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -110.96% | 3,500.00% | 1,971.43% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -94.45% | -- | 12,114.29% | -- | 195.40% |
| Cash from Investing | -94.62% | 12,400.00% | 4,736.54% | 3,500.00% | 198.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00% | -- | -42.86% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 0.00% | -- | -42.86% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -181.53% | 66.17% | 107.48% | 45.42% | 122.99% |